Effect of cataract surgery in patients with neovascular age-related macular degeneration: further evidence from disciform scars
To evaluate the effect of cataract surgery on disease activation and visual outcomes in neovascular age-related macular degeneration (AMD).
In this retrospective case–control study, study arm consisted of neovascular AMD patients, who underwent phacoemulsification surgery. Patients did not have any disease activation at least 6 months before the inclusion, and all had at least 12-month follow-up thereafter. Control group consisted of phakic patients, who did not undergo eye surgery during the study period. Primary outcomes were the presence of the disease activation and the change in best-corrected visual acuity (BCVA).
A total of 114 neovascular AMD patients [55 (48%) in exudative group and 59 (52%) in disciform group] were included. Preoperative logMAR BCVA was significantly improved after cataract surgery [0.8 (0.6–1.0) vs. 0.4 (0.4–0.7), P < 0.001 in exudative AMD; 1.85 (1.1–1.9) vs. 1.09 (0.8–1.9), P = 0.001 in disciform scar], but this improvement was not maintained during the study period in patients with both exudative AMD and disciform scar [0.6 (0.3–1.1), P = 0.313 in exudative AMD; 1.30 (1–1.9), P = 0.03 in disciform scar]. The incidence of disease activation was not statistically significant between surgery and control groups in patients with exudative AMD [5 (25%) patients in surgery group and 8 (22%) patients in the control group, P = 0.886, Cox proportional hazards regression analysis]. In disciform scar, disease activation was observed in 4 (17%) patients in the surgery group; however, no patient in the control group had disease activation (P = 0.009, HRs could not be estimated, 95% CI 0.001–43.49, Cox proportional hazards regression analysis).
Cataract surgery has benefit on early postoperative visual improvement in patients with neovascular AMD. The incidence of disease activation was not affected after surgery in exudative AMD.
KeywordsCataract surgery Disciform scar Neovascular age-related macular degeneration
Compliance with ethical standards
Conflict of interest
- 4.Jaffe GJ, Martin DF, Toth CA, Daniel E, Maguire MG, Ying GS, Grunwald JE, Huang J (2013) Comparison of age-related macular degeneration treatments trials research g: macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology 120:1860–1870CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Lee TG, Kim JH, Chang YS, Kim CG, Kim JW (2014) Factors influencing the exudation recurrence after cataract surgery in patients previously treated with anti-vascular endothelial growth factor for exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 252:1573–1579CrossRefPubMedGoogle Scholar
- 11.Grixti A, Papavasileiou E, Cortis D, Kumar BV, Prasad S (2014) Phacoemulsification surgery in eyes with neovascular age-related macular degeneration. ISRN Ophthalmol 2014:417603Google Scholar
- 12.Forooghian F, Agron E, Clemons TE, Ferris FL, Chew EY, Age-Related Eye Disease Study Research G (2009) Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27. Ophthalmology 116:2093–2100CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Saraf SS, Ryu CL, Ober MD (2015) The effects of cataract surgery on patients with wet macular degeneration. Am J Ophthalmol 160(487–492):e481Google Scholar
- 15.Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M (2007) An optical coherence tomography guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143:566–583CrossRefPubMedGoogle Scholar
- 19.Hartnett ME, Tinkham N, Paynter L, Geisen P, Rosenberg P, Koch G, Cohen KL (2009) Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol 148(895–901):e891Google Scholar
- 21.Ueta T, Inoue T, Yuda K, Furukawa T, Yanagi Y, Tamaki Y (2012) Intense physiological light upregulates vascular endothelial growth factor and enhances choroidal neovascularization via peroxisome proliferator-activated receptor gamma coactivator-1α in mice. Arterioscler Thromb Vasc Biol 32:1366–1371CrossRefPubMedGoogle Scholar